Literature DB >> 22649069

Parathyroid hormone-related protein stimulates plasma renin activity via its anorexic effects on sodium chloride intake.

Douglas K Atchison1, Elizabeth Westrick, David L Szandzik, Kevin L Gordish, William H Beierwaltes.   

Abstract

Parathyroid hormone-related protein (PTHrP) increases renin release from isolated perfused kidneys and may act as an autacoid regulator of renin secretion, but its effects on renin in vivo are unknown. In vivo, PTHrP causes hypercalcemia and anorexia, which may affect renin. We hypothesized that chronically elevated PTHrP would increase plasma renin activity (PRA) indirectly via its anorexic effects, reducing sodium chloride (NaCl) intake and causing NaCl restriction. We infused male Sprague-Dawley rats with the vehicle (control) or 125 μg PTHrP/day (PTHrP) via subcutaneous osmotic minipumps for 5 days. To replenish NaCl consumption, a third group of PTHrP-infused rats received 0.3% NaCl (PTHrP + NaCl) in their drinking water. PTHrP increased PRA from a median control value of 3.68 to 18.4 ng Ang I·ml(-1)·h(-1) (P < 0.05), whereas the median PTHrP + NaCl PRA value was normal (7.82 ng Ang I·ml(-1)·h(-1), P < 0.05 vs. PTHrP). Plasma Ca(2+) (median control: 10.2 mg/dl; PTHrP: 13.7 mg/dl; PTHrP + NaCl: 14.1 mg/dl; P < 0.05) and PTHrP (median control: 0.03 ng/ml; PTHrP: 0.12 ng/ml; PTHrP + NaCl: 0.15 ng/ml; P < 0.05) were elevated in PTHrP- and PTHrP + NaCl-treated rats. Body weights and caloric consumption were lower in PTHrP- and PTHrP + NaCl-treated rats. NaCl consumption was lower in PTHrP-treated rats (mean Na(+): 28.5 ± 4.1 mg/day; mean Cl(-): 47.8 mg/day) compared with controls (Na(+): 67.3 ± 2.7 mg/day; Cl(-): 112.8 ± 4.6 mg/day; P < 0.05). NaCl consumption was comparable with control in the PTHrP + NaCl group; 0.3% NaCl in the drinking water had no effect on PRA in normal rats. Thus, our data support the hypothesis that PTHrP increases PRA via its anorexic effects, reducing NaCl intake and causing NaCl restriction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22649069      PMCID: PMC3423101          DOI: 10.1152/ajpendo.00020.2012

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  46 in total

1.  Expression of PTHrP, PTH/PTHrP receptor, and Ca(2+)-sensing receptor mRNAs along the rat nephron.

Authors:  T Yang; S Hassan; Y G Huang; A M Smart; J P Briggs; J B Schnermann
Journal:  Am J Physiol       Date:  1997-06

2.  INFLUENCE OF SODIUM DEPRIVATION AND LOADING ON THE PLASMA-RENIN IN MAN.

Authors:  J J BROWN; D L DAVIES; A F LEVER; J I ROBERTSON
Journal:  J Physiol       Date:  1964-10       Impact factor: 5.182

3.  CONTROL OF RENIN SECRETION IN THE ANESTHETIZED DOG.

Authors:  A J VANDER; R MILLER
Journal:  Am J Physiol       Date:  1964-09

4.  RENAL BARORECEPTOR CONTROL OF ACUTE RENIN RELEASE IN NORMOTENSIVE, NEPHROGENIC AND NEUROGENIC HYPERTENSIVE DOGS.

Authors:  S L SKINNER; J W MCCUBBIN; I H PAGE
Journal:  Circ Res       Date:  1964-12       Impact factor: 17.367

5.  Parathyroid hormone-related protein induces cachectic syndromes without directly modulating the expression of hypothalamic feeding-regulating peptides.

Authors:  Hirofumi Hashimoto; Yumiko Azuma; Makoto Kawasaki; Hiroaki Fujihara; Etsuro Onuma; Hisafumi Yamada-Okabe; Yoh Takuwa; Etsuro Ogata; Yoichi Ueta
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

6.  Hemodynamic effects of parathyroid hormone-related peptide-(1-34) in humans.

Authors:  M Wolzt; L Schmetterer; G Dorner; G Zelger; J Entlicher; S Kapiotis; H G Eichler
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

7.  Rat model of the hypercalcaemia induced by parathyroid hormone-related protein: characteristics of three bisphosphonates.

Authors:  Yoshimitsu Komatsu; Yohsuke Imai; Fumiaki Itoh; Masami Kojima; Masayuki Isaji; Nobuo Shibata
Journal:  Eur J Pharmacol       Date:  2004-12-19       Impact factor: 4.432

8.  Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery.

Authors:  G Bernini; A Moretti; S Lonzi; C Bendinelli; P Miccoli; A Salvetti
Journal:  Metabolism       Date:  1999-03       Impact factor: 8.694

9.  Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts.

Authors:  Etsuro Onuma; Toshiaki Tsunenari; Hidemi Saito; Koh Sato; Hisafumi Yamada-Okabe; Etsuro Ogata
Journal:  Int J Cancer       Date:  2005-09-01       Impact factor: 7.396

10.  Preservation of intracellular renin expression is insufficient to compensate for genetic loss of secreted renin.

Authors:  Di Xu; Giulianna R Borges; Justin L Grobe; Christopher J Pelham; Baoli Yang; Curt D Sigmund
Journal:  Hypertension       Date:  2009-10-12       Impact factor: 10.190

View more
  4 in total

1.  Parathyroid hormone stimulates juxtaglomerular cell cAMP accumulation without stimulating renin release.

Authors:  Douglas K Atchison; Pamela Harding; M Cecilia Ortiz-Capisano; Edward L Peterson; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-15

2.  Juxtaglomerular cell CaSR stimulation decreases renin release via activation of the PLC/IP(3) pathway and the ryanodine receptor.

Authors:  M Cecilia Ortiz-Capisano; Mahendranath Reddy; Mariela Mendez; Jeffrey L Garvin; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-05

3.  Vitamin D increases plasma renin activity independently of plasma Ca2+ via hypovolemia and β-adrenergic activity.

Authors:  Douglas K Atchison; Pamela Harding; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-07

4.  Differences in various biochemical and clinical parameters with respect to family history of Non Communicable Diseases in fourth year MBBS students of Karachi, Pakistan.

Authors:  Khalid Abdul Basit; Asher Fawwad; Muhammad Asadullah Munir; Iftikhar Ahmed Siddiqui; Sidra Siddiqui; Abdul Basit
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.